UPenn will spin out Jim Wilson’s gene therapy program and split it into two companies
The University of Pennsylvania board of trustees voted Wednesday to spin out its pioneering Gene Therapy Program led by prominent research scientist Jim Wilson into two new for-profit companies amid decreased investment in biotech. Wilson will be CEO of …